Correlation of tumor necrosis factor alpha and interleukin 6 with hypertensive renal damage

REFERENCES

• Cymerys M, Chyrek R, Bogdanski P, Lacki J, Pupek-Musialik D. Evaluation of acute phase proteins in hypertensive and obese patients. Pol Merkuriusz Lek. 2003;15:352–355.
   PubMedGoogle Scholar
• Bogdanski P, Kujawska-Luczak M, Lacki J, Pupek-Musialik D. Evaluation of selected interleukins, tumor necrosis factor, insulin and leptin in obese patient with hypertension. Pol Merkuriusz Lek. 2003;15:347–351.
   PubMedGoogle Scholar
• Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2005;19:149–154.
   PubMed Web of Science ®Google Scholar
• Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension. 2001; 38:399–403.
   PubMed Web of Science ®Google Scholar
• Cottone S, Vadalà A, Vella MC, Mulé G, Contorno A, Cerasola G. Comparison of tumor necrosis factor and endothelin-1 between essential and renal hypertension patients. J Hum Hypertens. 1998;12:351–354.
   PubMedGoogle Scholar
• Dzielak DJ. The immune system and hypertension. Hypertension. 1992;19(Suppl. 1):I36–I44.
   PubMed Web of Science ®Google Scholar
• Sardo MA, Mandraffino G, Campo S, Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness. Clin Chim Acta. 2009; 406(1–2):89–93.
   PubMedGoogle Scholar
• Kim KI, Lee JH, Chang HJ, Association between blood pressure variability and inflammatory marker in hypertensive patients. Circ J. 2008;72:293–298.
   PubMed Web of Science ®Google Scholar
• Bivol LM, Berge RK, Iversen BM. Tetradecylthioacetic acid prevents the inflammatory response in two-kidney, one-clip hypertension. Am J Physiol Regul Integr Comp Physiol. 2008; 294:R438–R447.
   Google Scholar
• Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol. 1997;37:240–249.
   PubMed Web of Science ®Google Scholar
• Marsden PA, Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNF-α. Am J Physiol. 1992;262: C854–C861.
   Google Scholar
• Hajjar KA, Hajjar DP, Silverstein RL, Nachman RL. Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelia cells. J Exp Med. 1987;166: 235–245.
   PubMed Web of Science ®Google Scholar
• Van Hinsbergh VW, Kooistra T, van den Berg EA, Princen HM, Fiers W, Emeis JJ. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and rats in vivo. Blood. 1988;72:1467–1473.
   PubMed Web of Science ®Google Scholar
• Ikeda U, Ikeda M, Oohara T, Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol. 1991;260:H1713–H1717.
   Google Scholar
• Yoshizumi M, Perrella MA, Burnett JC Jr, Lee ME. Tumor necrosis factor down regulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res. 1993;73:205–209.
   PubMed Web of Science ®Google Scholar
• Naya M, Tsukamoto T, Morita K, Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients. Hypertens Res. 2007;30:541–548.
   PubMed Web of Science ®Google Scholar
• Han Y, Runge MS, Brasier AR. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor kappa B transcription factors. Circ Res. 1999;84:695–703.
   PubMed Web of Science ®Google Scholar
• Skurk T, van Harmelen V, Hauner H. Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of nuclear factor kappa B. Arterioscler Thromb Vasc Biol. 2004;24:1199–1203.
   PubMed Web of Science ®Google Scholar
• Kranzhöfer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P, Kübler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;19:1623–1629.
   PubMed Web of Science ®Google Scholar
• Brasier AR, Li J, Wimbish KA. Tumor necrosis factor activates angiotensinogen gene expression by Rel A transactivator. Hypertension. 1996;27:1009–1017.
   PubMed Web of Science ®Google Scholar
• Takano M, Itoh N, Yayama K, Yamano M, Ohtani R, Okamoto H. Interleukin-6 as a mediator responsible for inflammation-induced increase in plasma angiotensinogen. Biochem Pharmacol. 1993;45:201–206.
   PubMedGoogle Scholar
• Buemi M, Marino D, Floccari F, Effect of interleukin-8 and ICAM-1 on calcium-dependent outflow of K+ in erythrocytes from subjects with essential hypertension. Curr Med Res Opin. 2004;20:19–24.
   PubMed Web of Science ®Google Scholar
• Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension. 2005;46: 1118–1122.
   PubMed Web of Science ®Google Scholar
• Simmons EM, Himmelfarb J, Sezer MT, Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int. 2004;65:1357–1365.
   PubMed Web of Science ®Google Scholar
• Pecoits-Filho R, Bárány P, Lindholm B, Heimbürger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant. 2002;17:1684–1688.
   PubMed Web of Science ®Google Scholar
• Coletta I, Soldo L, Polentarutti N, Selective induction of MCP-1 in human mesangial cells by the IL-6/sIL-6R complex. Exp Nephrol. 2000;8:37–43.
   PubMedGoogle Scholar
• Nanami M, Ookawara T, Otaki Y, Tumor necrosis factor alpha induced iron sequestration and oxidative stress in human endothelial cells. Arterioscler Thromb Vasc Biol. 2005;25:2495–2501.
   PubMedGoogle Scholar
• Sterzel RB, Schulze-Lohoff E, Marx M. Cytokines and mesangial cells. Kidney Int Suppl. 1993;39:26–31.
   Google Scholar
• Ruef C, Budde K, Lacy J, Interleukin 6 is an autocrine growth factor for mesangial cells. Kidney Int. 1990; 38:249–257.
   PubMedGoogle Scholar
• Horii Y, Muraguchi A, Iwano M, Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol. 1989; 143:3949–3955.
   PubMed Web of Science ®Google Scholar
• Ritz E, Stefanski A. Diabetic nephropathy in type2 diabetes. Am J Kidney Dis. 1996;27:167–194.
   PubMed Web of Science ®Google Scholar